Shares of Nanthealth LLC (NYSE:NH) saw strong trading volume on Wednesday . 216,675 shares traded hands during trading, an increase of 113% from the previous session’s volume of 101,572 shares.The stock last traded at $12.30 and had previously closed at $12.76.

Several equities research analysts recently issued reports on the company. First Analysis assumed coverage on Nanthealth in a report on Monday, June 27th. They set an “overweight” rating and a $18.00 price target for the company. Jefferies Group assumed coverage on Nanthealth in a report on Monday, June 27th. They set a “buy” rating for the company. FBR & Co assumed coverage on Nanthealth in a research note on Monday, June 27th. They issued an “outperform” rating and a $18.00 price objective for the company. Canaccord Genuity assumed coverage on Nanthealth in a research note on Monday, June 27th. They issued a “buy” rating and a $17.00 price objective for the company. Finally, Cowen and Company assumed coverage on Nanthealth in a research note on Monday, June 27th. They issued an “outperform” rating and a $19.00 price objective for the company. Five research analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and a consensus price target of $18.00.

The stock’s market cap is $1.47 billion. The company’s 50-day moving average price is $11.55 and its 200 day moving average price is $12.39.

Nanthealth (NYSE:NH) last announced its quarterly earnings data on Tuesday, August 9th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.41) by $0.26. The company had revenue of $31.50 million for the quarter, compared to analysts’ expectations of $23.55 million. The company’s revenue for the quarter was up 166.9% compared to the same quarter last year. Equities analysts forecast that Nanthealth LLC will post ($0.59) earnings per share for the current fiscal year.

In other Nanthealth news, major shareholder Healthcare Solution Allscripts bought 714,286 shares of Nanthealth stock in a transaction on Tuesday, June 7th. The stock was acquired at an average price of $14.00 per share, with a total value of $10,000,004.00. Following the acquisition, the insider now owns 15,000,000 shares in the company, valued at $210,000,000. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Patrick Soon-Shiong bought 357,143 shares of Nanthealth stock in a transaction on Tuesday, June 7th. The stock was acquired at an average cost of $14.00 per share, with a total value of $5,000,002.00. The disclosure for this purchase can be found here.

Nant Health, LLC is an evidence-based, personalized healthcare company. The Company’s systems-based approach to personalized healthcare applies diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with real-time biometric signal and phenotypic data to track patient outcomes and deliver medicine.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.